Sunao Manabe
Chief Executive Officer en DAIICHI SANKYO CO., LTD. .
Cargos activos de Sunao Manabe
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DAIICHI SANKYO CO., LTD. | Chief Executive Officer | 01/06/2019 | - |
Chairman | - | - | |
Director/Board Member | 01/06/2014 | - | |
Chief Operating Officer | 01/04/2017 | 01/06/2019 | |
Human Resources Officer | 01/06/2016 | 01/04/2017 | |
Corporate Officer/Principal | 01/04/2007 | 01/06/2016 | |
President | 01/04/2017 | - | |
Sales & Marketing | 01/04/2015 | 01/04/2016 | |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Corporate Officer/Principal | 12/07/2023 | - |
Historial de carrera de Sunao Manabe
Estadísticas
Internacional
Suiza | 2 |
Japón | 2 |
Operativa
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
DAIICHI SANKYO CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
- Bolsa de valores
- Insiders
- Sunao Manabe
- Experiencia